Search research articles
Contact Us
Filters
Showing results (241-250 of 251) with videos related to
Page
of 26
Sort By:
Advances in Radiation Oncology
|
April 11, 2025
Cell-Free Circulating Tumor DNA for NonInvasive Molecular Profiling Among Patients Undergoing Definitive Chemoradiation for Locally Advanced Lung Cancer
Emily S Lebow, Jordan Eichholz, Lillian Boe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 2, 2023
Stereotactic body radiation therapy for sarcoma pulmonary metastases
Emily S Lebow, Stephanie M Lobaugh, Zhigang Zhang, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLC
Annemarie F Shepherd, Anthony F Yu, Michelle Iocolano, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 4, 2025
American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-Small Cell Lung Cancer Executive Summary
Charles B Simone, Arya Amini, Indrin J Chetty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2025
Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer
Andreas Rimner, Benjamin H Lok, Daphna Y Gelblum, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 28, 2023
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation Trial
Andreas Rimner, Daphna Y Gelblum, Abraham J Wu, et al.
Practical Radiation Oncology
|
June 16, 2026
Prophylactic versus therapeutic sucralfate in patients at high risk for radiation esophagitis: randomized controlled trial
Jacob Y Shin, Melissa Assel, Abraham J Wu, et al.
Lancet (London, England)
|
December 17, 2023
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
Chiaojung Jillian Tsai, Jonathan T Yang, Narek Shaverdian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2023
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis
Andreas Rimner, Zachary R Moore, Stephanie Lobaugh, et al.
JTO Clinical and Research Reports
|
January 2, 2023
A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma
Andreas Rimner, Prasad S Adusumilli, Michael D Offin, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 251) with videos related to
Sort By:
Page
of 26
Advances in Radiation Oncology
|
April 11, 2025
Cell-Free Circulating Tumor DNA for NonInvasive Molecular Profiling Among Patients Undergoing Definitive Chemoradiation for Locally Advanced Lung Cancer
Emily S Lebow, Jordan Eichholz, Lillian Boe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 2, 2023
Stereotactic body radiation therapy for sarcoma pulmonary metastases
Emily S Lebow, Stephanie M Lobaugh, Zhigang Zhang, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLC
Annemarie F Shepherd, Anthony F Yu, Michelle Iocolano, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 4, 2025
American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-Small Cell Lung Cancer Executive Summary
Charles B Simone, Arya Amini, Indrin J Chetty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2025
Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer
Andreas Rimner, Benjamin H Lok, Daphna Y Gelblum, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 28, 2023
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation Trial
Andreas Rimner, Daphna Y Gelblum, Abraham J Wu, et al.
Practical Radiation Oncology
|
June 16, 2026
Prophylactic versus therapeutic sucralfate in patients at high risk for radiation esophagitis: randomized controlled trial
Jacob Y Shin, Melissa Assel, Abraham J Wu, et al.
Lancet (London, England)
|
December 17, 2023
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
Chiaojung Jillian Tsai, Jonathan T Yang, Narek Shaverdian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2023
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis
Andreas Rimner, Zachary R Moore, Stephanie Lobaugh, et al.
JTO Clinical and Research Reports
|
January 2, 2023
A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma
Andreas Rimner, Prasad S Adusumilli, Michael D Offin, et al.
Page
of 26